Is the price fair?
What KMTS's price assumes
Kestra Medical Technologies, Ltd. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is read against sales instead: 12.7× revenue.
12.7
Price / sales · no P/E: the last twelve months did not end in a profit
- EV / sales
- 12.1
EV / sales
Details›
- EV / EBIToperating margin −142%: the multiple describes the denominator
- not meaningful
- EV / sales2026-Q2
- 12.1
- Market capitalisation
- $1.16B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Instruments & Supplies
Ranks #26 of 27 by Smart Score